Novo Nordisk A/S surged on expectations that some competition for its blockbuster obesity shot Wegovy will subside, paving ...

Novo Nordisk shares jumped following stronger-than-expected first-quarter earnings, despite the company lowering its growth ...

Novo Nordisk stock rose after the Danish pharma giant posted better-than-expected quarterly earnings, but cut its guidance ...

AstraZeneca, the FTSE 100’s largest stock, was down 2 per cent and GSK fell 4 per cent after the US Food and Drug ...

Novo Nordisk has announced it will eliminate gender representation requirements in the United States, citing legal changes, ...